INFI Infinity Pharmaceuticals Inc

Price (delayed)

$3.04

Market cap

$195.19M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.71

Enterprise value

$178.22M

Sector: Healthcare
Industry: Biotechnology

Highlights

INFI's debt is down by 20% year-on-year and by 8% since the previous quarter
Infinity Pharmaceuticals's EPS has increased by 7% YoY and by 5% QoQ
The company's gross profit fell by 45% YoY but it rose by 11% QoQ
The revenue has declined by 45% year-on-year but it has grown by 11% since the previous quarter
The company's equity has shrunk by 176% YoY and by 24% QoQ
Infinity Pharmaceuticals's quick ratio has decreased by 30% YoY and by 13% QoQ

Key stats

What are the main financial stats of INFI
Market
Shares outstanding
64.21M
Market cap
$195.19M
Enterprise value
$178.22M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
115.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
111.95
Earnings
Revenue
$1.59M
EBIT
-$39.44M
EBITDA
-$38.93M
Free cash flow
-$36.92M
Per share
EPS
-$0.71
Free cash flow per share
-$0.61
Book value per share
-$0.24
Revenue per share
$0.03
TBVPS
$0.78
Balance sheet
Total assets
$46.97M
Total liabilities
$61.09M
Debt
$1.56M
Equity
-$14.13M
Working capital
$33.64M
Liquidity
Debt to equity
-0.11
Current ratio
4.42
Quick ratio
4.2
Net debt/EBITDA
0.44
Margins
EBITDA margin
-2,445.6%
Gross margin
100%
Net margin
-2,592.7%
Operating margin
-2,501.1%
Efficiency
Return on assets
-81.8%
Return on equity
N/A
Return on invested capital
-222.1%
Return on capital employed
-106.2%
Return on sales
-2,477.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INFI stock price

How has the Infinity Pharmaceuticals stock price performed over time
Intraday
-4.4%
1 week
-19.36%
1 month
-20.21%
1 year
139.37%
YTD
43.4%
QTD
43.4%

Financial performance

How have Infinity Pharmaceuticals's revenue and profit performed over time
Revenue
$1.59M
Gross profit
$1.59M
Operating income
-$39.82M
Net income
-$41.28M
Gross margin
100%
Net margin
-2,592.7%
INFI's net margin has dropped by 71% year-on-year but it is up by 14% since the previous quarter
INFI's operating margin has shrunk by 70% YoY but it is up by 13% QoQ
The company's gross profit fell by 45% YoY but it rose by 11% QoQ
The revenue has declined by 45% year-on-year but it has grown by 11% since the previous quarter

Growth

What is Infinity Pharmaceuticals's growth rate over time

Valuation

What is Infinity Pharmaceuticals stock price valuation
P/E
N/A
P/B
N/A
P/S
115.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
111.95
Infinity Pharmaceuticals's EPS has increased by 7% YoY and by 5% QoQ
The company's equity has shrunk by 176% YoY and by 24% QoQ
The revenue has declined by 45% year-on-year but it has grown by 11% since the previous quarter

Efficiency

How efficient is Infinity Pharmaceuticals business performance
Infinity Pharmaceuticals's return on sales has shrunk by 73% YoY but it has increased by 13% QoQ
INFI's return on assets is down by 22% year-on-year
Infinity Pharmaceuticals's ROIC has decreased by 11% from the previous quarter but it has increased by 9% YoY

Dividends

What is INFI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INFI.

Financial health

How did Infinity Pharmaceuticals financials performed over time
Infinity Pharmaceuticals's total assets is 23% less than its total liabilities
Infinity Pharmaceuticals's quick ratio has decreased by 30% YoY and by 13% QoQ
INFI's current ratio is down by 29% year-on-year and by 12% since the previous quarter
INFI's debt is 111% greater than its equity
The debt to equity has plunged by 200% YoY but it is up by 27% from the previous quarter
The company's equity has shrunk by 176% YoY and by 24% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.